United States Financial Markets News
Sign up for free!
Get instant access to all of our market news and analysis with our free REST API.
Search entities
Discover all 32,649 supported financial entities for United States financial markets here.
Latest news
Live response for past 24 hours
{
"meta": {
"found": 1985,
"returned": 10,
"limit": 10,
"page": 1
},
"data": [
{
"uuid": "fc183baa-491c-4aaf-8680-f4c354795a42",
"title": "FDA Approval Boosts Novavax (NVAX) with $200M Milestone | NVAX Stock News",
"description": "The U.S. Food and Drug Administration has approved Nuvaxovid, a vaccine developed for the prevention of COVID-19 in adults 65 and over, as well as individuals a",
"keywords": "GuruFocus, Article, News, GuruFocus News, NVAX",
"snippet": "The U.S. Food and Drug Administration has approved Nuvaxovid, a vaccine developed for the prevention of COVID-19 in adults 65 and over, as well as individuals a...",
"url": "https://www.gurufocus.com/news/2874680/fda-approval-boosts-novavax-nvax-with-200m-milestone-nvax-stock-news",
"image_url": "https://static.gurufocus.com/logos/0C00000BWN.png?20",
"language": "en",
"published_at": "2025-05-19T20:45:27.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "NVAX",
"name": "Novavax, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 54.301308,
"sentiment_score": 0.477122,
"highlights": [
{
"highlight": "This decision significantly benefits <em[+245 characters]",
"sentiment": 0.3818,
"highlighted_in": "main_text"
},
{
"highlight": "The firm continues to uphold its Buy rec[+316 characters]",
"sentiment": 0.0258,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+333 characters]",
"sentiment": 0.5106,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+239 characters]",
"sentiment": 0.7579,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+211 characters]",
"sentiment": 0.3182,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Points\n\n<em>Novavax</em> <em>In[+286 characters]",
"sentiment": 0.9153,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Novavax</em> <em>Inc</em> (NVAX) is [+271 characters]",
"sentiment": 0.8779,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Novavax</em> <em>Inc</em> (NVAX) is [+143 characters]",
"sentiment": -0.1531,
"highlighted_in": "main_text"
},
{
"highlight": "FDA Approval Boosts <em>Novavax</em> (NVAX) with $200M Milestone | NVAX Stock News",
"sentiment": 0.6597,
"highlighted_in": "title"
}
]
}
],
"similar": [
{
"uuid": "ea9fcb2c-e662-409e-92c4-446892d82aba",
"title": "US Credit Rating Downgrade Affects Market; Novavax (NVAX) Surges on FDA Vaccine Approval",
"description": "The recent downgrade of the US credit rating by Moody's has caused significant disruption in the US capital market. All three major stock indices opened lower,",
"keywords": "GuruFocus, Article, News, GuruFocus News, NVAX",
"snippet": "The recent downgrade of the US credit rating by Moody's has caused significant disruption in the US capital market. All three major stock indices opened lower, ...",
"url": "https://www.gurufocus.com/news/2873809/us-credit-rating-downgrade-affects-market-novavax-nvax-surges-on-fda-vaccine-approval",
"image_url": "https://static.gurufocus.com/logos/0C00000BWN.png?20",
"language": "en",
"published_at": "2025-05-19T15:10:16.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "NVDA",
"name": "NVIDIA Corporation",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Technology",
"match_score": 14.280881,
"sentiment_score": 0.296,
"highlights": [
{
"highlight": "Tesla fell nearly 4%, while <em>Nvidia</[+281 characters]",
"sentiment": 0.296,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "TSLA",
"name": "Tesla, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Consumer Cyclical",
"match_score": 13.938282,
"sentiment_score": 0.296,
"highlights": [
{
"highlight": "<em>Tesla</em> fell nearly 4%, while Nvi[+281 characters]",
"sentiment": 0.296,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "NVAX",
"name": "Novavax, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 35.75992,
"sentiment_score": 0.7046,
"highlights": [
{
"highlight": "In contrast, <em>Novavax</em> (NVAX, Fin[+231 characters]",
"sentiment": 0.7184,
"highlighted_in": "main_text"
},
{
"highlight": "US Credit Rating Downgrade Affects Market; <em>Novavax</em> (NVAX) Surges on FDA Vaccine Approval",
"sentiment": 0.6908,
"highlighted_in": "title"
}
]
}
]
},
{
"uuid": "9a3c93cc-dcf3-4d80-bd44-ce7f3aeb8f87",
"title": "Novavax (NVAX) Surges After FDA Approves COVID-19 Vaccine",
"description": "Key Highlights:\n Novavax (NVAX) shares surged over 17% in premarket trading after FDA approval of its COVID-19 vaccine, Nuvaxovid, for high-risk groups. A",
"keywords": "GuruFocus, Article, News, GuruFocus News, NVAX",
"snippet": "Key Highlights:\n\nNovavax (NVAX, Financial) shares surged over 17% in premarket trading after FDA approval of its COVID-19 vaccine, Nuvaxovid, for high-risk grou...",
"url": "https://www.gurufocus.com/news/2873324/novavax-nvax-surges-after-fda-approves-covid19-vaccine",
"image_url": "https://static.gurufocus.com/logos/0C00000BWN.png?20",
"language": "en",
"published_at": "2025-05-19T13:56:12.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "NVAX",
"name": "Novavax, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 54.27043,
"sentiment_score": 0.4435,
"highlights": [
{
"highlight": "Key Highlights:\n\n<em>Novavax</em> (NVAX,[+311 characters]",
"sentiment": 0.6908,
"highlighted_in": "main_text"
},
{
"highlight": "Novavax's FDA Approval Sparks Market Exc[+314 characters]",
"sentiment": 0.8807,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Offer Optimistic Ou[+209 characters]",
"sentiment": 0.7096,
"highlighted_in": "main_text"
},
{
"highlight": "For more precise estimates, visit the <e[+275 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Assessing the GF Value and Market Implic[+186 characters]",
"sentiment": 0.4215,
"highlighted_in": "main_text"
},
{
"highlight": "For a deeper dive into Novavax’s curre[+109 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Novavax</em> (NVAX) Surges After FDA Approves COVID-19 Vaccine",
"sentiment": 0.4019,
"highlighted_in": "title"
}
]
},
{
"symbol": "NVAX.MX",
"name": "Novavax, Inc.",
"exchange": null,
"exchange_long": null,
"country": "mx",
"type": "equity",
"industry": "Healthcare",
"match_score": 54.23469,
"sentiment_score": 0.4435,
"highlights": [
{
"highlight": "Key Highlights:\n\n<em>Novavax</em> (NVAX,[+311 characters]",
"sentiment": 0.6908,
"highlighted_in": "main_text"
},
{
"highlight": "Novavax's FDA Approval Sparks Market Exc[+314 characters]",
"sentiment": 0.8807,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Offer Optimistic Ou[+209 characters]",
"sentiment": 0.7096,
"highlighted_in": "main_text"
},
{
"highlight": "For more precise estimates, visit the <e[+275 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Assessing the GF Value and Market Implic[+186 characters]",
"sentiment": 0.4215,
"highlighted_in": "main_text"
},
{
"highlight": "For a deeper dive into Novavax’s curre[+109 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Novavax</em> (NVAX) Surges After FDA Approves COVID-19 Vaccine",
"sentiment": 0.4019,
"highlighted_in": "title"
}
]
},
{
"symbol": "0A3S.L",
"name": "Novavax, Inc.",
"exchange": null,
"exchange_long": null,
"country": "gb",
"type": "equity",
"industry": "N/A",
"match_score": 54.225258,
"sentiment_score": 0.4435,
"highlights": [
{
"highlight": "Key Highlights:\n\n<em>Novavax</em> (NVAX,[+311 characters]",
"sentiment": 0.6908,
"highlighted_in": "main_text"
},
{
"highlight": "Novavax's FDA Approval Sparks Market Exc[+314 characters]",
"sentiment": 0.8807,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Offer Optimistic Ou[+209 characters]",
"sentiment": 0.7096,
"highlighted_in": "main_text"
},
{
"highlight": "For more precise estimates, visit the <e[+275 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Assessing the GF Value and Market Implic[+186 characters]",
"sentiment": 0.4215,
"highlighted_in": "main_text"
},
{
"highlight": "For a deeper dive into Novavax’s curre[+109 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Novavax</em> (NVAX) Surges After FDA Approves COVID-19 Vaccine",
"sentiment": 0.4019,
"highlighted_in": "title"
}
]
}
]
},
{
"uuid": "9271bd03-2f28-4d24-8b3c-9ace625203e2",
"title": "Novavax Inc (NVAX) Receives FDA Approval for Nuvaxovid COVID-19 Vaccine | NVAX stock news",
"description": "Summary On May 19, 2025, Novavax Inc (NVAX) announced that the U.S. Food and Drug Administration (FDA) has approved the Biologics License Application (BLA) for",
"keywords": "GuruFocus, Article, News, GuruFocus News, NVAX",
"snippet": "Summary\n\nOn May 19, 2025, Novavax Inc (NVAX, Financial) announced that the U.S. Food and Drug Administration (FDA) has approved the Biologics License Applicatio...",
"url": "https://www.gurufocus.com/news/2873063/novavax-inc-nvax-receives-fda-approval-for-nuvaxovid-covid19-vaccine-nvax-stock-news",
"image_url": "https://static.gurufocus.com/images/global_logo_twitter_card.png",
"language": "en",
"published_at": "2025-05-19T13:01:58.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "0A3S.L",
"name": "Novavax, Inc.",
"exchange": null,
"exchange_long": null,
"country": "gb",
"type": "equity",
"industry": "N/A",
"match_score": 71.04616,
"sentiment_score": 0.392425,
"highlights": [
{
"highlight": "Summary\n\nOn May 19, 2025, <em>Novavax</e[+57 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Novavax</em> is eligible for ongoing[+246 characters]",
"sentiment": 0.3182,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Novavax</em> faces challenges relate[+58 characters]",
"sentiment": 0.0772,
"highlighted_in": "main_text"
},
{
"highlight": "Financial Analyst Perspective\n\nFrom a fi[+313 characters]",
"sentiment": 0.3506,
"highlighted_in": "main_text"
},
{
"highlight": "Market Research Analyst Perspective\n\nFro[+234 characters]",
"sentiment": 0.5859,
"highlighted_in": "main_text"
},
{
"highlight": "Nuvaxovid is a recombinant protein-based[+296 characters]",
"sentiment": 0.4767,
"highlighted_in": "main_text"
},
{
"highlight": "What financial impact does the FDA appro[+213 characters]",
"sentiment": 0.8541,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Novavax</em> <em>Inc</em> (NVAX) Receives FDA Approval for Nuvaxovid COVID-19 Vaccine | NVAX stock news",
"sentiment": 0.4767,
"highlighted_in": "title"
}
]
},
{
"symbol": "NVAX",
"name": "Novavax, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 71.04087,
"sentiment_score": 0.392425,
"highlights": [
{
"highlight": "Summary\n\nOn May 19, 2025, <em>Novavax</e[+57 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Novavax</em> is eligible for ongoing[+246 characters]",
"sentiment": 0.3182,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Novavax</em> faces challenges relate[+58 characters]",
"sentiment": 0.0772,
"highlighted_in": "main_text"
},
{
"highlight": "Financial Analyst Perspective\n\nFrom a fi[+313 characters]",
"sentiment": 0.3506,
"highlighted_in": "main_text"
},
{
"highlight": "Market Research Analyst Perspective\n\nFro[+234 characters]",
"sentiment": 0.5859,
"highlighted_in": "main_text"
},
{
"highlight": "Nuvaxovid is a recombinant protein-based[+296 characters]",
"sentiment": 0.4767,
"highlighted_in": "main_text"
},
{
"highlight": "What financial impact does the FDA appro[+213 characters]",
"sentiment": 0.8541,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Novavax</em> <em>Inc</em> (NVAX) Receives FDA Approval for Nuvaxovid COVID-19 Vaccine | NVAX stock news",
"sentiment": 0.4767,
"highlighted_in": "title"
}
]
},
{
"symbol": "NVAX.MX",
"name": "Novavax, Inc.",
"exchange": null,
"exchange_long": null,
"country": "mx",
"type": "equity",
"industry": "Healthcare",
"match_score": 71.05141,
"sentiment_score": 0.392425,
"highlights": [
{
"highlight": "Summary\n\nOn May 19, 2025, <em>Novavax</e[+57 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Novavax</em> is eligible for ongoing[+246 characters]",
"sentiment": 0.3182,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Novavax</em> faces challenges relate[+58 characters]",
"sentiment": 0.0772,
"highlighted_in": "main_text"
},
{
"highlight": "Financial Analyst Perspective\n\nFrom a fi[+313 characters]",
"sentiment": 0.3506,
"highlighted_in": "main_text"
},
{
"highlight": "Market Research Analyst Perspective\n\nFro[+234 characters]",
"sentiment": 0.5859,
"highlighted_in": "main_text"
},
{
"highlight": "Nuvaxovid is a recombinant protein-based[+296 characters]",
"sentiment": 0.4767,
"highlighted_in": "main_text"
},
{
"highlight": "What financial impact does the FDA appro[+213 characters]",
"sentiment": 0.8541,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Novavax</em> <em>Inc</em> (NVAX) Receives FDA Approval for Nuvaxovid COVID-19 Vaccine | NVAX stock news",
"sentiment": 0.4767,
"highlighted_in": "title"
}
]
}
]
},
{
"uuid": "887b4102-e0e3-423e-b457-40fc62839b96",
"title": "Novavax (NVAX) Secures FDA Approval for COVID-19 Vaccine | NVAX Stock News",
"description": "Novavax (NVAX) has received approval from the U.S. Food and Drug Administration for its Biologics License Application for Nuvaxovid. This vaccine is designed fo",
"keywords": "GuruFocus, Article, News, GuruFocus News, NVAX",
"snippet": "Novavax (NVAX, Financial) has received approval from the U.S. Food and Drug Administration for its Biologics License Application for Nuvaxovid. This vaccine is ...",
"url": "https://www.gurufocus.com/news/2872829/novavax-nvax-secures-fda-approval-for-covid19-vaccine-nvax-stock-news",
"image_url": "https://static.gurufocus.com/logos/0C00000BWN.png?20",
"language": "en",
"published_at": "2025-05-19T12:17:00.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "NVAX.MX",
"name": "Novavax, Inc.",
"exchange": null,
"exchange_long": null,
"country": "mx",
"type": "equity",
"industry": "Healthcare",
"match_score": 53.272305,
"sentiment_score": 0.49125,
"highlights": [
{
"highlight": "<em>Novavax</em> (NVAX, Financial) has r[+112 characters]",
"sentiment": 0.4767,
"highlighted_in": "main_text"
},
{
"highlight": "As a result of this partnership, <em>Nov[+276 characters]",
"sentiment": 0.8225,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+277 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+333 characters]",
"sentiment": 0.5106,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+236 characters]",
"sentiment": 0.7579,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+211 characters]",
"sentiment": 0.3182,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Points\n\n<em>Novavax</em> <em>In[+286 characters]",
"sentiment": 0.9153,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Novavax</em> <em>Inc</em> (NVAX) is [+271 characters]",
"sentiment": 0.8779,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Novavax</em> <em>Inc</em> (NVAX) is [+143 characters]",
"sentiment": -0.1531,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Novavax</em> (NVAX) Secures FDA Approval for COVID-19 Vaccine | NVAX Stock News",
"sentiment": 0.6597,
"highlighted_in": "title"
}
]
},
{
"symbol": "0A3S.L",
"name": "Novavax, Inc.",
"exchange": null,
"exchange_long": null,
"country": "gb",
"type": "equity",
"industry": "N/A",
"match_score": 53.25286,
"sentiment_score": 0.49125,
"highlights": [
{
"highlight": "<em>Novavax</em> (NVAX, Financial) has r[+112 characters]",
"sentiment": 0.4767,
"highlighted_in": "main_text"
},
{
"highlight": "As a result of this partnership, <em>Nov[+276 characters]",
"sentiment": 0.8225,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+277 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+333 characters]",
"sentiment": 0.5106,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+236 characters]",
"sentiment": 0.7579,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+211 characters]",
"sentiment": 0.3182,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Points\n\n<em>Novavax</em> <em>In[+286 characters]",
"sentiment": 0.9153,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Novavax</em> <em>Inc</em> (NVAX) is [+271 characters]",
"sentiment": 0.8779,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Novavax</em> <em>Inc</em> (NVAX) is [+143 characters]",
"sentiment": -0.1531,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Novavax</em> (NVAX) Secures FDA Approval for COVID-19 Vaccine | NVAX Stock News",
"sentiment": 0.6597,
"highlighted_in": "title"
}
]
},
{
"symbol": "NVAX",
"name": "Novavax, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 53.248802,
"sentiment_score": 0.49125,
"highlights": [
{
"highlight": "<em>Novavax</em> (NVAX, Financial) has r[+112 characters]",
"sentiment": 0.4767,
"highlighted_in": "main_text"
},
{
"highlight": "As a result of this partnership, <em>Nov[+276 characters]",
"sentiment": 0.8225,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+277 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+333 characters]",
"sentiment": 0.5106,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+236 characters]",
"sentiment": 0.7579,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+211 characters]",
"sentiment": 0.3182,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Points\n\n<em>Novavax</em> <em>In[+286 characters]",
"sentiment": 0.9153,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Novavax</em> <em>Inc</em> (NVAX) is [+271 characters]",
"sentiment": 0.8779,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Novavax</em> <em>Inc</em> (NVAX) is [+143 characters]",
"sentiment": -0.1531,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Novavax</em> (NVAX) Secures FDA Approval for COVID-19 Vaccine | NVAX Stock News",
"sentiment": 0.6597,
"highlighted_in": "title"
}
]
}
]
},
{
"uuid": "e3a4a8bf-fcf4-4d18-9108-508dc214be9a",
"title": "NVAX Surges 15% Following FDA Approval of COVID Vaccine | NVAX Stock News",
"description": "Novavax (NVAX) experienced a notable rise in its stock price, increasing by 15% to reach $7.73. This surge followed the U.S. Food and Drug Administration's appr",
"keywords": "GuruFocus, Article, News, GuruFocus News, NVAX",
"snippet": "Novavax (NVAX, Financial) experienced a notable rise in its stock price, increasing by 15% to reach $7.73. This surge followed the U.S. Food and Drug Administra...",
"url": "https://www.gurufocus.com/news/2872820/nvax-surges-15-following-fda-approval-of-covid-vaccine-nvax-stock-news",
"image_url": "https://static.gurufocus.com/logos/0C00000BWN.png?20",
"language": "en",
"published_at": "2025-05-19T12:16:23.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "NVAX.MX",
"name": "Novavax, Inc.",
"exchange": null,
"exchange_long": null,
"country": "mx",
"type": "equity",
"industry": "Healthcare",
"match_score": 40.433937,
"sentiment_score": 0.477425,
"highlights": [
{
"highlight": "<em>Novavax</em> (NVAX, Financial) exper[+317 characters]",
"sentiment": 0.8658,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+277 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+333 characters]",
"sentiment": 0.5106,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+236 characters]",
"sentiment": 0.7579,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+211 characters]",
"sentiment": 0.3182,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Points\n\n<em>Novavax</em> <em>In[+286 characters]",
"sentiment": 0.9153,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Novavax</em> <em>Inc</em> (NVAX) is [+271 characters]",
"sentiment": 0.8779,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Novavax</em> <em>Inc</em> (NVAX) is [+143 characters]",
"sentiment": -0.1531,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "0A3S.L",
"name": "Novavax, Inc.",
"exchange": null,
"exchange_long": null,
"country": "gb",
"type": "equity",
"industry": "N/A",
"match_score": 40.424862,
"sentiment_score": 0.477425,
"highlights": [
{
"highlight": "<em>Novavax</em> (NVAX, Financial) exper[+317 characters]",
"sentiment": 0.8658,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+277 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+333 characters]",
"sentiment": 0.5106,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+236 characters]",
"sentiment": 0.7579,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+211 characters]",
"sentiment": 0.3182,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Points\n\n<em>Novavax</em> <em>In[+286 characters]",
"sentiment": 0.9153,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Novavax</em> <em>Inc</em> (NVAX) is [+271 characters]",
"sentiment": 0.8779,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Novavax</em> <em>Inc</em> (NVAX) is [+143 characters]",
"sentiment": -0.1531,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "NVAX",
"name": "Novavax, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 40.422516,
"sentiment_score": 0.477425,
"highlights": [
{
"highlight": "<em>Novavax</em> (NVAX, Financial) exper[+317 characters]",
"sentiment": 0.8658,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+277 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+333 characters]",
"sentiment": 0.5106,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+236 characters]",
"sentiment": 0.7579,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+211 characters]",
"sentiment": 0.3182,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Points\n\n<em>Novavax</em> <em>In[+286 characters]",
"sentiment": 0.9153,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Novavax</em> <em>Inc</em> (NVAX) is [+271 characters]",
"sentiment": 0.8779,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Novavax</em> <em>Inc</em> (NVAX) is [+143 characters]",
"sentiment": -0.1531,
"highlighted_in": "main_text"
}
]
}
]
}
]
},
{
"uuid": "74432e95-73ff-49d9-9236-f2ce64681911",
"title": "JPMorgan Adjusts Alstom (ALSMY) Price Target to EUR 25 | ALSMY Stock News",
"description": "JPMorgan has revised its price target for Alstom (ALSMY), reducing it from EUR 26 to EUR 25. Despite this adjustment, the firm maintains its Overweight rating o",
"keywords": "GuruFocus, Article, News, GuruFocus News, ALSMY",
"snippet": "JPMorgan has revised its price target for Alstom (ALSMY, Financial), reducing it from EUR 26 to EUR 25. Despite this adjustment, the firm maintains its Overweig...",
"url": "https://www.gurufocus.com/news/2874677/jpmorgan-adjusts-alstom-alsmy-price-target-to-eur-25-alsmy-stock-news",
"image_url": "https://static.gurufocus.com/logos/0C000009TF.png?20",
"language": "en",
"published_at": "2025-05-19T20:30:36.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "ALSMY",
"name": "Alstom SA",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Industrials",
"match_score": 105.64642,
"sentiment_score": 0.455025,
"highlights": [
{
"highlight": "JPMorgan has revised its price target fo[+234 characters]",
"sentiment": 0.6369,
"highlighted_in": "main_text"
},
{
"highlight": "This move suggests an expectation for <e[+295 characters]",
"sentiment": 0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Points\n\n<em>Alstom</em> <em>SA<[+234 characters]",
"sentiment": 0.91,
"highlighted_in": "main_text"
},
{
"highlight": "JPMorgan Adjusts <em>Alstom</em> (<em>ALSMY</em>) Price Target to EUR 25 | <em>ALSMY</em> Stock News",
"sentiment": 0,
"highlighted_in": "title"
}
]
},
{
"symbol": "AOMFF",
"name": "Alstom SA",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Industrials",
"match_score": 45.839737,
"sentiment_score": 0.455025,
"highlights": [
{
"highlight": "JPMorgan has revised its price target fo[+225 characters]",
"sentiment": 0.6369,
"highlighted_in": "main_text"
},
{
"highlight": "This move suggests an expectation for <e[+286 characters]",
"sentiment": 0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Points\n\n<em>Alstom</em> <em>SA<[+225 characters]",
"sentiment": 0.91,
"highlighted_in": "main_text"
},
{
"highlight": "JPMorgan Adjusts <em>Alstom</em> (ALSMY) Price Target to EUR 25 | ALSMY Stock News",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
],
"similar": [
{
"uuid": "fa194205-bae2-417b-afb0-d5b534ff6ce7",
"title": "Morgan Stanley Adjusts Primerica (PRI) Price Target to $296 | PRI Stock News",
"description": "Morgan Stanley has increased its price target for Primerica (PRI) from $274 to $296, while maintaining an Equal Weight rating on the stock. This revision is par",
"keywords": "GuruFocus, Article, News, GuruFocus News, PRI",
"snippet": "Morgan Stanley has increased its price target for Primerica (PRI, Financial) from $274 to $296, while maintaining an Equal Weight rating on the stock. This revi...",
"url": "https://www.gurufocus.com/news/2873690/morgan-stanley-adjusts-primerica-pri-price-target-to-296-pri-stock-news",
"image_url": "https://static.gurufocus.com/logos/0C00004A1X.png?20",
"language": "en",
"published_at": "2025-05-19T14:47:45.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "PRI",
"name": "Primerica, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Financial Services",
"match_score": 61.998726,
"sentiment_score": 0.418675,
"highlights": [
{
"highlight": "Morgan Stanley has increased its price t[+231 characters]",
"sentiment": 0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+282 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+329 characters]",
"sentiment": 0.5106,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+241 characters]",
"sentiment": 0.7579,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+297 characters]",
"sentiment": 0.4939,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Primerica</em> Life Estimated RPC Ra[+262 characters]",
"sentiment": 0.7906,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Primerica</em> <em>Inc</em> (PRI, Fi[+257 characters]",
"sentiment": 0.7964,
"highlighted_in": "main_text"
},
{
"highlight": "Morgan Stanley Adjusts <em>Primerica</em> (PRI) Price Target to $296 | PRI Stock News",
"sentiment": 0,
"highlighted_in": "title"
}
]
},
{
"symbol": "MSCL.SN",
"name": "MORGAN STANLEY",
"exchange": null,
"exchange_long": null,
"country": "cl",
"type": "equity",
"industry": "N/A",
"match_score": 91.7029,
"sentiment_score": 0.133733,
"highlights": [
{
"highlight": "<em>Morgan</em> <em>Stanley</em> has inc[+240 characters]",
"sentiment": 0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Morgan</em> <em>Stanley</em> finds t[+316 characters]",
"sentiment": 0.128,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Morgan</em> <em>Stanley</em> Adjusts Primerica (PRI) Price Target to $296 | PRI Stock News",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
]
},
{
"uuid": "e01e5418-e9f6-4250-a733-b64db85e0eb3",
"title": "JPMorgan Adjusts Price Target for Urban Outfitters (URBN) | URBN Stock News",
"description": "JPMorgan has updated its price target for Urban Outfitters (URBN), lifting it from $50 to $63 while maintaining a Neutral rating on the stock. This revision com",
"keywords": "GuruFocus, Article, News, GuruFocus News, URBN",
"snippet": "JPMorgan has updated its price target for Urban Outfitters (URBN, Financial), lifting it from $50 to $63 while maintaining a Neutral rating on the stock. This r...",
"url": "https://www.gurufocus.com/news/2872817/jpmorgan-adjusts-price-target-for-urban-outfitters-urbn-urbn-stock-news",
"image_url": "https://static.gurufocus.com/logos/0C00000CVW.png?20",
"language": "en",
"published_at": "2025-05-19T12:16:12.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "URBN",
"name": "Urban Outfitters, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Consumer Cyclical",
"match_score": 93.6199,
"sentiment_score": 0.212914,
"highlights": [
{
"highlight": "JPMorgan has updated its price target fo[+245 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+298 characters]",
"sentiment": -0.4767,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+277 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+257 characters]",
"sentiment": 0.7579,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+234 characters]",
"sentiment": 0.3182,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Points\n\n<em>Urban</em> <em>Outf[+299 characters]",
"sentiment": 0.891,
"highlighted_in": "main_text"
},
{
"highlight": "JPMorgan Adjusts Price Target for <em>Urban</em> <em>Outfitters</em> (URBN) | URBN Stock News",
"sentiment": 0,
"highlighted_in": "title"
}
]
},
{
"symbol": "URBN.BA",
"name": "Urban Outfitters, Inc.",
"exchange": null,
"exchange_long": null,
"country": "ar",
"type": "equity",
"industry": "Consumer Cyclical",
"match_score": 93.6322,
"sentiment_score": 0.212914,
"highlights": [
{
"highlight": "JPMorgan has updated its price target fo[+245 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+298 characters]",
"sentiment": -0.4767,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+277 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+257 characters]",
"sentiment": 0.7579,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+234 characters]",
"sentiment": 0.3182,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Points\n\n<em>Urban</em> <em>Outf[+299 characters]",
"sentiment": 0.891,
"highlighted_in": "main_text"
},
{
"highlight": "JPMorgan Adjusts Price Target for <em>Urban</em> <em>Outfitters</em> (URBN) | URBN Stock News",
"sentiment": 0,
"highlighted_in": "title"
}
]
},
{
"symbol": "UOF.DE",
"name": "Urban Outfitters, Inc.",
"exchange": null,
"exchange_long": null,
"country": "de",
"type": "equity",
"industry": "Consumer Cyclical",
"match_score": 93.63093,
"sentiment_score": 0.212914,
"highlights": [
{
"highlight": "JPMorgan has updated its price target fo[+245 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+298 characters]",
"sentiment": -0.4767,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+277 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+257 characters]",
"sentiment": 0.7579,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+234 characters]",
"sentiment": 0.3182,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Points\n\n<em>Urban</em> <em>Outf[+299 characters]",
"sentiment": 0.891,
"highlighted_in": "main_text"
},
{
"highlight": "JPMorgan Adjusts Price Target for <em>Urban</em> <em>Outfitters</em> (URBN) | URBN Stock News",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
]
},
{
"uuid": "e17f430f-b2e2-4950-b5e8-a7904d704d18",
"title": "JPMorgan Boosts Price Target for Ollie's Bargain Outlet (OLLI) | OLLI Stock News",
"description": "JPMorgan has increased its price target for Ollie's Bargain Outlet (OLLI) from $135 to $137, maintaining an Overweight rating. This adjustment comes as part of",
"keywords": "GuruFocus, Article, News, GuruFocus News, OLLI",
"snippet": "JPMorgan has increased its price target for Ollie's Bargain Outlet (OLLI, Financial) from $135 to $137, maintaining an Overweight rating. This adjustment comes ...",
"url": "https://www.gurufocus.com/news/2872809/jpmorgan-boosts-price-target-for-ollies-bargain-outlet-olli-olli-stock-news",
"image_url": "https://static.gurufocus.com/logos/0C0000AXTF.png?20",
"language": "en",
"published_at": "2025-05-19T12:15:46.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "OLLI",
"name": "Ollie's Bargain Outlet Holdings, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Consumer Defensive",
"match_score": 104.09146,
"sentiment_score": 0.39698,
"highlights": [
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+333 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+349 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+292 characters]",
"sentiment": 0.7579,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+349 characters]",
"sentiment": 0.7906,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Points\n\n<em>Ollie's</em> <em>Ba[+178 characters]",
"sentiment": 0.7096,
"highlighted_in": "main_text"
}
]
}
]
}
]
},
{
"uuid": "2dab179e-fc7a-4f4c-a505-72a393952a27",
"title": "XP Inc (XP) Experiences Unusual Bearish Options Activity | XP Stock News",
"description": "XP Inc (XP) has seen significant bearish activity in the options market, with a total of 48,678 put contracts traded, which is five times the usual amount. The",
"keywords": "GuruFocus, Article, News, GuruFocus News, XP",
"snippet": "XP Inc (XP, Financial) has seen significant bearish activity in the options market, with a total of 48,678 put contracts traded, which is five times the usual a...",
"url": "https://www.gurufocus.com/news/2874673/xp-inc-xp-experiences-unusual-bearish-options-activity-xp-stock-news",
"image_url": "https://static.gurufocus.com/logos/0C0000BQJH.png?20",
"language": "en",
"published_at": "2025-05-19T20:30:25.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "XP",
"name": "XP Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Financial Services",
"match_score": 46.96172,
"sentiment_score": 0.338317,
"highlights": [
{
"highlight": "<em>XP</em> <em>Inc</em> (XP, Financial)[+250 characters]",
"sentiment": 0.2023,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+271 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+311 characters]",
"sentiment": 0.7672,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+232 characters]",
"sentiment": 0.8176,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+42 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>XP</em> <em>Inc</em> (XP) Experiences Unusual Bearish Options Activity | XP Stock News",
"sentiment": 0.516,
"highlighted_in": "title"
}
]
}
],
"similar": []
},
{
"uuid": "a235a51e-2c52-415a-a84d-0273e1a09d47",
"title": "Travel Safely on Ohio's Lakeshore Roads During Mayfly Season | FE Stock News",
"description": "FirstEnergy Corp. (FE) to suspend streetlight service in select Lake Erie communities to mitigate mayfly-related road hazards. The suspension will begin",
"keywords": "GuruFocus, Article, News, GuruFocus News, FE",
"snippet": "FirstEnergy Corp. (FE, Financial) to suspend streetlight service in select Lake Erie communities to mitigate mayfly-related road hazards.\n\nThe suspension will b...",
"url": "https://www.gurufocus.com/news/2874672/travel-safely-on-ohios-lakeshore-roads-during-mayfly-season-fe-stock-news",
"image_url": "https://static.gurufocus.com/logos/0C000007OQ.png?20",
"language": "en",
"published_at": "2025-05-19T20:30:25.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "FE",
"name": "FirstEnergy Corp.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Utilities",
"match_score": 43.570442,
"sentiment_score": 0.50894,
"highlights": [
{
"highlight": "<em>FirstEnergy</em> <em>Corp</em>. (FE,[+243 characters]",
"sentiment": -0.3182,
"highlighted_in": "main_text"
},
{
"highlight": "Ohio Edison, a subsidiary of <em>FirstEn[+245 characters]",
"sentiment": 0.6808,
"highlighted_in": "main_text"
},
{
"highlight": "To ensure public safety, Ohio Edison, a [+234 characters]",
"sentiment": 0.7845,
"highlighted_in": "main_text"
},
{
"highlight": "In the interim, <em>FirstEnergy</em> adv[+254 characters]",
"sentiment": 0.5574,
"highlighted_in": "main_text"
},
{
"highlight": "<em>FirstEnergy</em> is committed to mai[+226 characters]",
"sentiment": 0.8402,
"highlighted_in": "main_text"
}
]
}
],
"similar": []
},
{
"uuid": "a12bf009-3329-498f-9ef4-3fbc68b19b2b",
"title": "Citi Adjusts Price Target for Euronext (EUXTF) Amid Neutral Stance | EUXTF Stock News",
"description": "Citi has revised its price target for Euronext (EUXTF), increasing it from EUR 140 to EUR 147. Despite this adjustment, the firm maintains a Neutral rating on t",
"keywords": "GuruFocus, Article, News, GuruFocus News, EUXTF",
"snippet": "Citi has revised its price target for Euronext (EUXTF, Financial), increasing it from EUR 140 to EUR 147. Despite this adjustment, the firm maintains a Neutral ...",
"url": "https://www.gurufocus.com/news/2874671/citi-adjusts-price-target-for-euronext-euxtf-amid-neutral-stance-euxtf-stock-news",
"image_url": "https://static.gurufocus.com/logos/0C00000VRY.png?20",
"language": "en",
"published_at": "2025-05-19T20:30:16.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "EUXTF",
"name": "Euronext N.V.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Financial Services",
"match_score": 92.29387,
"sentiment_score": 0.40524,
"highlights": [
{
"highlight": "Citi has revised its price target for <e[+308 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>EUXTF</em> Key Business Developments[+274 characters]",
"sentiment": 0.34,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Points\n\n<em>Euronext</em> NV (<[+274 characters]",
"sentiment": 0.9432,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Euronext</em> NV (<em>EUXTF</em>) an[+335 characters]",
"sentiment": 0.743,
"highlighted_in": "main_text"
},
{
"highlight": "Citi Adjusts Price Target for <em>Euronext</em> (<em>EUXTF</em>) Amid Neutral Stance | <em>EUXTF</em> Stock News",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
],
"similar": [
{
"uuid": "523e493e-fc8a-45ae-b5f0-d1f9ccaa6d42",
"title": "Truist Adjusts DaVita (DVA) Price Target Downward | DVA Stock News",
"description": "Truist has revised its price target for DaVita (DVA), lowering it from $170 to $164, while maintaining a Hold rating on the shares. This adjustment follows an a",
"keywords": "GuruFocus, Article, News, GuruFocus News, DVA",
"snippet": "Truist has revised its price target for DaVita (DVA, Financial), lowering it from $170 to $164, while maintaining a Hold rating on the shares. This adjustment f...",
"url": "https://www.gurufocus.com/news/2873665/truist-adjusts-davita-dva-price-target-downward-dva-stock-news",
"image_url": "https://static.gurufocus.com/logos/0C00000AVY.png?20",
"language": "en",
"published_at": "2025-05-19T14:45:16.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "DVA",
"name": "DaVita Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 61.916714,
"sentiment_score": 0.463375,
"highlights": [
{
"highlight": "Truist has revised its price target for [+306 characters]",
"sentiment": 0.7845,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+280 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+324 characters]",
"sentiment": 0.5106,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+238 characters]",
"sentiment": 0.7579,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+305 characters]",
"sentiment": 0.2023,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Points\n\n<em>DaVita</em> <em>Inc[+199 characters]",
"sentiment": 0.8807,
"highlighted_in": "main_text"
},
{
"highlight": "Despite a cybersecurity incident, <em>Da[+250 characters]",
"sentiment": 0.8442,
"highlighted_in": "main_text"
},
{
"highlight": "Truist Adjusts <em>DaVita</em> (DVA) Price Target Downward | DVA Stock News",
"sentiment": 0,
"highlighted_in": "title"
}
]
},
{
"symbol": "DVA.MX",
"name": "DaVita Inc.",
"exchange": null,
"exchange_long": null,
"country": "mx",
"type": "equity",
"industry": "Healthcare",
"match_score": 61.906494,
"sentiment_score": 0.463375,
"highlights": [
{
"highlight": "Truist has revised its price target for [+306 characters]",
"sentiment": 0.7845,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+280 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+324 characters]",
"sentiment": 0.5106,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+238 characters]",
"sentiment": 0.7579,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+305 characters]",
"sentiment": 0.2023,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Points\n\n<em>DaVita</em> <em>Inc[+199 characters]",
"sentiment": 0.8807,
"highlighted_in": "main_text"
},
{
"highlight": "Despite a cybersecurity incident, <em>Da[+250 characters]",
"sentiment": 0.8442,
"highlighted_in": "main_text"
},
{
"highlight": "Truist Adjusts <em>DaVita</em> (DVA) Price Target Downward | DVA Stock News",
"sentiment": 0,
"highlighted_in": "title"
}
]
},
{
"symbol": "0I7E.L",
"name": "DaVita Inc.",
"exchange": null,
"exchange_long": null,
"country": "gb",
"type": "equity",
"industry": "N/A",
"match_score": 61.88073,
"sentiment_score": 0.463375,
"highlights": [
{
"highlight": "Truist has revised its price target for [+306 characters]",
"sentiment": 0.7845,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+280 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+324 characters]",
"sentiment": 0.5106,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+238 characters]",
"sentiment": 0.7579,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+305 characters]",
"sentiment": 0.2023,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Points\n\n<em>DaVita</em> <em>Inc[+199 characters]",
"sentiment": 0.8807,
"highlighted_in": "main_text"
},
{
"highlight": "Despite a cybersecurity incident, <em>Da[+250 characters]",
"sentiment": 0.8442,
"highlighted_in": "main_text"
},
{
"highlight": "Truist Adjusts <em>DaVita</em> (DVA) Price Target Downward | DVA Stock News",
"sentiment": 0,
"highlighted_in": "title"
}
]
},
{
"symbol": "DVAI34.SA",
"name": "DaVita Inc.",
"exchange": null,
"exchange_long": null,
"country": "br",
"type": "equity",
"industry": "Healthcare",
"match_score": 61.87184,
"sentiment_score": 0.463375,
"highlights": [
{
"highlight": "Truist has revised its price target for [+306 characters]",
"sentiment": 0.7845,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+280 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+324 characters]",
"sentiment": 0.5106,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+238 characters]",
"sentiment": 0.7579,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+305 characters]",
"sentiment": 0.2023,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Points\n\n<em>DaVita</em> <em>Inc[+199 characters]",
"sentiment": 0.8807,
"highlighted_in": "main_text"
},
{
"highlight": "Despite a cybersecurity incident, <em>Da[+250 characters]",
"sentiment": 0.8442,
"highlighted_in": "main_text"
},
{
"highlight": "Truist Adjusts <em>DaVita</em> (DVA) Price Target Downward | DVA Stock News",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
]
},
{
"uuid": "bc4aeaad-982e-47d8-9c03-da3a9ef209f7",
"title": "GSBD: BofA Adjusts Price Target Following Mixed Quarter | GSBD Stock News",
"description": "Bank of America has revised its price target for Goldman Sachs BDC (GSBD), bringing it down from $12 to $11.25. Despite maintaining a Neutral rating on the stoc",
"keywords": "GuruFocus, Article, News, GuruFocus News, GSBD",
"snippet": "Bank of America has revised its price target for Goldman Sachs BDC (GSBD, Financial), bringing it down from $12 to $11.25. Despite maintaining a Neutral rating ...",
"url": "https://www.gurufocus.com/news/2873247/gsbd-bofa-adjusts-price-target-following-mixed-quarter-gsbd-stock-news",
"image_url": "https://static.gurufocus.com/images/global_logo_twitter_card.png",
"language": "en",
"published_at": "2025-05-19T13:33:59.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "GSBD",
"name": "Goldman Sachs BDC, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Financial Services",
"match_score": 80.16826,
"sentiment_score": 0.233567,
"highlights": [
{
"highlight": "Bank of America has revised its price ta[+252 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+307 characters]",
"sentiment": -0.4767,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+296 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+266 characters]",
"sentiment": 0.7579,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+239 characters]",
"sentiment": 0.3182,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Points\n\n<em>Goldman</em> <em>Sa[+324 characters]",
"sentiment": 0.802,
"highlighted_in": "main_text"
}
]
}
]
}
]
},
{
"uuid": "0b51d64c-1a78-4c86-8bfc-cb9632271ae4",
"title": "Watts Water Technologies, Inc. to Participate in Upcoming Investor Conferences | WTS Stock News",
"description": "Watts Water Technologies (WTS) will engage in three major investor conferences in late May and early June 2025. Key executives including CEO Robert J. P",
"keywords": "GuruFocus, Article, News, GuruFocus News, WTS",
"snippet": "Watts Water Technologies (WTS, Financial) will engage in three major investor conferences in late May and early June 2025.\n\nKey executives including CEO Robert ...",
"url": "https://www.gurufocus.com/news/2874670/watts-water-technologies-inc-to-participate-in-upcoming-investor-conferences-wts-stock-news",
"image_url": "https://static.gurufocus.com/logos/0C000009LV.png?20",
"language": "en",
"published_at": "2025-05-19T20:30:14.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "WTS",
"name": "Watts Water Technologies, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Industrials",
"match_score": 158.3001,
"sentiment_score": 0.5031,
"highlights": [
{
"highlight": "<em>Watts</em> <em>Water</em> <em>Techno[+363 characters]",
"sentiment": 0.7506,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Watts</em> <em>Water</em> <em>Techno[+207 characters]",
"sentiment": 0.2023,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Watts</em> <em>Water</em> <em>Techno[+207 characters]",
"sentiment": 0.7184,
"highlighted_in": "main_text"
},
{
"highlight": "With a market capitalization of $7.84 bi[+181 characters]",
"sentiment": 0.8442,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Watts</em> <em>Water</em> <em>Technologies</em>, <em>Inc</em>. to Participate in Upcoming Investor Conferences | WTS Stock News",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
],
"similar": [
{
"uuid": "45a4b520-563f-4741-9a37-c08fe196c085",
"title": "Viomi Technology (VIOT) Launches Innovative Kunlun 4 Pro Water Purifier | VIOT Stock News",
"description": "Viomi Technology (VIOT) has introduced its latest innovation, the Kunlun 4 Pro Alkaline Mineral Water Purifier. Unveiled during a dedicated event on May 16th, t",
"keywords": "GuruFocus, Article, News, GuruFocus News, VIOT",
"snippet": "Viomi Technology (VIOT, Financial) has introduced its latest innovation, the Kunlun 4 Pro Alkaline Mineral Water Purifier. Unveiled during a dedicated event on ...",
"url": "https://www.gurufocus.com/news/2873534/viomi-technology-viot-launches-innovative-kunlun-4-pro-water-purifier-viot-stock-news",
"image_url": "https://static.gurufocus.com/images/global_logo_twitter_card.png",
"language": "en",
"published_at": "2025-05-19T14:15:50.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "VIOT",
"name": "Viomi Technology Co., Ltd",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Technology",
"match_score": 56.741985,
"sentiment_score": 0.62215,
"highlights": [
{
"highlight": "Positive Points\n\n<em>Viomi</em> <em>Tech[+331 characters]",
"sentiment": 0.3818,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Viomi</em> <em>Technology</em> <em>C[+330 characters]",
"sentiment": 0.8625,
"highlighted_in": "main_text"
}
]
}
]
},
{
"uuid": "1d9875c1-6280-418a-8c5d-50189dfb0480",
"title": "Viomi Unveils Next-Generation Mineral Water Purifiers, Leading Household Drinking Water into the Era of Pure Mineral Water | VIOT Stock News",
"description": "Viomi (VIOT) launches Kunlun 4 Pro Alkaline Mineral Water Purifier, shifting focus from pure to enriched mineral water. The company invested over RMB 10",
"keywords": "GuruFocus, Article, News, GuruFocus News, VIOT",
"snippet": "Viomi (VIOT, Financial) launches Kunlun 4 Pro Alkaline Mineral Water Purifier, shifting focus from pure to enriched mineral water.\n\nThe company invested over RM...",
"url": "https://www.gurufocus.com/news/2873455/viomi-unveils-nextgeneration-mineral-water-purifiers-leading-household-drinking-water-into-the-era-of-pure-mineral-water-viot-stock-news",
"image_url": "https://static.gurufocus.com/images/global_logo_twitter_card.png",
"language": "en",
"published_at": "2025-05-19T14:00:48.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "VIOT",
"name": "Viomi Technology Co., Ltd",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Technology",
"match_score": 74.89445,
"sentiment_score": 0.5994,
"highlights": [
{
"highlight": "GUANGZHOU, China, May 19, 2025 — <em>V[+318 characters]",
"sentiment": 0.5994,
"highlighted_in": "main_text"
}
]
}
]
}
]
},
{
"uuid": "ad37b89c-268a-4684-aa61-806d7b7982d9",
"title": "Citi Boosts Price Target for Atlas Copco (ATLKY) to SEK 187 | ATLKY Stock News",
"description": "Citi has increased its price target for Atlas Copco (ATLKY) from SEK 177 to SEK 187, maintaining a Buy recommendation for the stock. This adjustment reflects a",
"keywords": "GuruFocus, Article, News, GuruFocus News, ATLKY",
"snippet": "Citi has increased its price target for Atlas Copco (ATLKY, Financial) from SEK 177 to SEK 187, maintaining a Buy recommendation for the stock. This adjustment ...",
"url": "https://www.gurufocus.com/news/2874669/citi-boosts-price-target-for-atlas-copco-atlky-to-sek-187-atlky-stock-news",
"image_url": "https://static.gurufocus.com/logos/0C00000EAE.png?20",
"language": "en",
"published_at": "2025-05-19T20:30:13.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "ATLKY",
"name": "Atlas Copco AB",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Industrials",
"match_score": 159.21765,
"sentiment_score": 0.297067,
"highlights": [
{
"highlight": "Citi has increased its price target for [+225 characters]",
"sentiment": 0.4939,
"highlighted_in": "main_text"
},
{
"highlight": "Investors are encouraged to consider thi[+363 characters]",
"sentiment": 0.3818,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+370 characters]",
"sentiment": 0.5106,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+258 characters]",
"sentiment": 0.8176,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+71 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Citi Boosts Price Target for <em>Atlas</em> <em>Copco</em> (<em>ATLKY</em>) to SEK 187 | <em>ATLKY</em> Stock News",
"sentiment": -0.4215,
"highlighted_in": "title"
}
]
},
{
"symbol": "ATLCY",
"name": "Atlas Copco AB",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Industrials",
"match_score": 100.946686,
"sentiment_score": 0.297067,
"highlights": [
{
"highlight": "Citi has increased its price target for [+216 characters]",
"sentiment": 0.4939,
"highlighted_in": "main_text"
},
{
"highlight": "Investors are encouraged to consider thi[+354 characters]",
"sentiment": 0.3818,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+352 characters]",
"sentiment": 0.5106,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+249 characters]",
"sentiment": 0.8176,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+62 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Citi Boosts Price Target for <em>Atlas</em> <em>Copco</em> (ATLKY) to SEK 187 | ATLKY Stock News",
"sentiment": -0.4215,
"highlighted_in": "title"
}
]
},
{
"symbol": "ATLKF",
"name": "Atlas Copco AB",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Industrials",
"match_score": 100.91638,
"sentiment_score": 0.297067,
"highlights": [
{
"highlight": "Citi has increased its price target for [+216 characters]",
"sentiment": 0.4939,
"highlighted_in": "main_text"
},
{
"highlight": "Investors are encouraged to consider thi[+354 characters]",
"sentiment": 0.3818,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+352 characters]",
"sentiment": 0.5106,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+249 characters]",
"sentiment": 0.8176,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+62 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Citi Boosts Price Target for <em>Atlas</em> <em>Copco</em> (ATLKY) to SEK 187 | ATLKY Stock News",
"sentiment": -0.4215,
"highlighted_in": "title"
}
]
},
{
"symbol": "ATTLF",
"name": "Atlas Copco AB",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Industrials",
"match_score": 100.90176,
"sentiment_score": 0.297067,
"highlights": [
{
"highlight": "Citi has increased its price target for [+216 characters]",
"sentiment": 0.4939,
"highlighted_in": "main_text"
},
{
"highlight": "Investors are encouraged to consider thi[+354 characters]",
"sentiment": 0.3818,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+352 characters]",
"sentiment": 0.5106,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+249 characters]",
"sentiment": 0.8176,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+62 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Citi Boosts Price Target for <em>Atlas</em> <em>Copco</em> (ATLKY) to SEK 187 | ATLKY Stock News",
"sentiment": -0.4215,
"highlighted_in": "title"
}
]
}
],
"similar": [
{
"uuid": "c9276feb-dcda-4de9-8df3-49d8c62af596",
"title": "TD Cowen Boosts Netflix (NFLX) Price Target With Positive Member Forecast | NFLX Stock News",
"description": "TD Cowen has increased its price target for Netflix (NFLX) from $1,150 to $1,325 while maintaining a Buy rating on the stock. This adjustment follows a promisin",
"keywords": "GuruFocus, Article, News, GuruFocus News, NFLX",
"snippet": "TD Cowen has increased its price target for Netflix (NFLX, Financial) from $1,150 to $1,325 while maintaining a Buy rating on the stock. This adjustment follows...",
"url": "https://www.gurufocus.com/news/2872930/td-cowen-boosts-netflix-nflx-price-target-with-positive-member-forecast-nflx-stock-news",
"image_url": "https://static.gurufocus.com/logos/0C00000BRT.png?20",
"language": "en",
"published_at": "2025-05-19T12:46:43.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "NFLX",
"name": "Netflix, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Communication Services",
"match_score": 34.438416,
"sentiment_score": 0.523511,
"highlights": [
{
"highlight": "TD Cowen has increased its price target [+258 characters]",
"sentiment": 0.8074,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+290 characters]",
"sentiment": -0.4767,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+334 characters]",
"sentiment": 0.5106,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+242 characters]",
"sentiment": 0.7579,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+213 characters]",
"sentiment": 0.3182,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Points\n\n<em>Netflix</em> <em>In[+280 characters]",
"sentiment": 0.9584,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Netflix</em> <em>Inc</em> (NFLX) has[+210 characters]",
"sentiment": 0.765,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Netflix</em> <em>Inc</em> (NFLX) is [+172 characters]",
"sentiment": 0.3612,
"highlighted_in": "main_text"
},
{
"highlight": "TD Cowen Boosts <em>Netflix</em> (NFLX) Price Target With Positive Member Forecast | NFLX Stock News",
"sentiment": 0.7096,
"highlighted_in": "title"
}
]
},
{
"symbol": "NFLX34.SA",
"name": "Netflix, Inc.",
"exchange": null,
"exchange_long": null,
"country": "br",
"type": "equity",
"industry": "Communication Services",
"match_score": 34.437943,
"sentiment_score": 0.523511,
"highlights": [
{
"highlight": "TD Cowen has increased its price target [+258 characters]",
"sentiment": 0.8074,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+290 characters]",
"sentiment": -0.4767,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+334 characters]",
"sentiment": 0.5106,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+242 characters]",
"sentiment": 0.7579,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+213 characters]",
"sentiment": 0.3182,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Points\n\n<em>Netflix</em> <em>In[+280 characters]",
"sentiment": 0.9584,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Netflix</em> <em>Inc</em> (NFLX) has[+210 characters]",
"sentiment": 0.765,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Netflix</em> <em>Inc</em> (NFLX) is [+172 characters]",
"sentiment": 0.3612,
"highlighted_in": "main_text"
},
{
"highlight": "TD Cowen Boosts <em>Netflix</em> (NFLX) Price Target With Positive Member Forecast | NFLX Stock News",
"sentiment": 0.7096,
"highlighted_in": "title"
}
]
},
{
"symbol": "NFLX.BA",
"name": "Netflix, Inc.",
"exchange": null,
"exchange_long": null,
"country": "ar",
"type": "equity",
"industry": "Communication Services",
"match_score": 34.437332,
"sentiment_score": 0.523511,
"highlights": [
{
"highlight": "TD Cowen has increased its price target [+258 characters]",
"sentiment": 0.8074,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+290 characters]",
"sentiment": -0.4767,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+334 characters]",
"sentiment": 0.5106,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+242 characters]",
"sentiment": 0.7579,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+213 characters]",
"sentiment": 0.3182,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Points\n\n<em>Netflix</em> <em>In[+280 characters]",
"sentiment": 0.9584,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Netflix</em> <em>Inc</em> (NFLX) has[+210 characters]",
"sentiment": 0.765,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Netflix</em> <em>Inc</em> (NFLX) is [+172 characters]",
"sentiment": 0.3612,
"highlighted_in": "main_text"
},
{
"highlight": "TD Cowen Boosts <em>Netflix</em> (NFLX) Price Target With Positive Member Forecast | NFLX Stock News",
"sentiment": 0.7096,
"highlighted_in": "title"
}
]
},
{
"symbol": "NFLXD.BA",
"name": "NETFLIX INC",
"exchange": null,
"exchange_long": null,
"country": "ar",
"type": "equity",
"industry": "N/A",
"match_score": 34.437332,
"sentiment_score": 0.523511,
"highlights": [
{
"highlight": "TD Cowen has increased its price target [+258 characters]",
"sentiment": 0.8074,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+290 characters]",
"sentiment": -0.4767,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+334 characters]",
"sentiment": 0.5106,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+242 characters]",
"sentiment": 0.7579,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+213 characters]",
"sentiment": 0.3182,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Points\n\n<em>Netflix</em> <em>In[+280 characters]",
"sentiment": 0.9584,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Netflix</em> <em>Inc</em> (NFLX) has[+210 characters]",
"sentiment": 0.765,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Netflix</em> <em>Inc</em> (NFLX) is [+172 characters]",
"sentiment": 0.3612,
"highlighted_in": "main_text"
},
{
"highlight": "TD Cowen Boosts <em>Netflix</em> (NFLX) Price Target With Positive Member Forecast | NFLX Stock News",
"sentiment": 0.7096,
"highlighted_in": "title"
}
]
},
{
"symbol": "NFC.DE",
"name": "Netflix, Inc.",
"exchange": null,
"exchange_long": null,
"country": "de",
"type": "equity",
"industry": "Communication Services",
"match_score": 34.435944,
"sentiment_score": 0.523511,
"highlights": [
{
"highlight": "TD Cowen has increased its price target [+258 characters]",
"sentiment": 0.8074,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+290 characters]",
"sentiment": -0.4767,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+334 characters]",
"sentiment": 0.5106,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+242 characters]",
"sentiment": 0.7579,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+213 characters]",
"sentiment": 0.3182,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Points\n\n<em>Netflix</em> <em>In[+280 characters]",
"sentiment": 0.9584,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Netflix</em> <em>Inc</em> (NFLX) has[+210 characters]",
"sentiment": 0.765,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Netflix</em> <em>Inc</em> (NFLX) is [+172 characters]",
"sentiment": 0.3612,
"highlighted_in": "main_text"
},
{
"highlight": "TD Cowen Boosts <em>Netflix</em> (NFLX) Price Target With Positive Member Forecast | NFLX Stock News",
"sentiment": 0.7096,
"highlighted_in": "title"
}
]
},
{
"symbol": "NFLX.MX",
"name": "Netflix, Inc.",
"exchange": null,
"exchange_long": null,
"country": "mx",
"type": "equity",
"industry": "Communication Services",
"match_score": 34.435295,
"sentiment_score": 0.523511,
"highlights": [
{
"highlight": "TD Cowen has increased its price target [+258 characters]",
"sentiment": 0.8074,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+290 characters]",
"sentiment": -0.4767,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+334 characters]",
"sentiment": 0.5106,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+242 characters]",
"sentiment": 0.7579,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+213 characters]",
"sentiment": 0.3182,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Points\n\n<em>Netflix</em> <em>In[+280 characters]",
"sentiment": 0.9584,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Netflix</em> <em>Inc</em> (NFLX) has[+210 characters]",
"sentiment": 0.765,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Netflix</em> <em>Inc</em> (NFLX) is [+172 characters]",
"sentiment": 0.3612,
"highlighted_in": "main_text"
},
{
"highlight": "TD Cowen Boosts <em>Netflix</em> (NFLX) Price Target With Positive Member Forecast | NFLX Stock News",
"sentiment": 0.7096,
"highlighted_in": "title"
}
]
}
]
},
{
"uuid": "d8bed599-71ac-4b8b-b621-861f6e99ebdc",
"title": "Analog Devices (ADI) Price Target Raised Amid Positive Outlook | ADI Stock News",
"description": "Cantor Fitzgerald has adjusted its price target for Analog Devices (ADI), increasing it from $230 to $250 while maintaining a Neutral rating on the company's st",
"keywords": "GuruFocus, Article, News, GuruFocus News, ADI",
"snippet": "Cantor Fitzgerald has adjusted its price target for Analog Devices (ADI, Financial), increasing it from $230 to $250 while maintaining a Neutral rating on the c...",
"url": "https://www.gurufocus.com/news/2872908/analog-devices-adi-price-target-raised-amid-positive-outlook-adi-stock-news",
"image_url": "https://static.gurufocus.com/logos/0C00000ABQ.png?20",
"language": "en",
"published_at": "2025-05-19T12:45:17.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "ADI",
"name": "Analog Devices, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Technology",
"match_score": 26.95264,
"sentiment_score": 0.27818,
"highlights": [
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+297 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+259 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+256 characters]",
"sentiment": 0.7579,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+285 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Points\n\n<em>Analog</em> <em>Dev[+259 characters]",
"sentiment": 0.9062,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "ADI.BA",
"name": "Analog Devices, Inc.",
"exchange": null,
"exchange_long": null,
"country": "ar",
"type": "equity",
"industry": "Technology",
"match_score": 82.44242,
"sentiment_score": 0.339163,
"highlights": [
{
"highlight": "Cantor Fitzgerald has adjusted its price[+153 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "The firm anticipates that <em>Analog</em[+314 characters]",
"sentiment": 0.765,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+297 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+277 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+256 characters]",
"sentiment": 0.7579,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+285 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Points\n\n<em>Analog</em> <em>Dev[+259 characters]",
"sentiment": 0.9062,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Analog</em> <em>Devices</em> (ADI) Price Target Raised Amid Positive Outlook | ADI Stock News",
"sentiment": 0.5574,
"highlighted_in": "title"
}
]
},
{
"symbol": "ADID.BA",
"name": "ANALOG DEVICES INC",
"exchange": null,
"exchange_long": null,
"country": "ar",
"type": "equity",
"industry": "N/A",
"match_score": 82.44246,
"sentiment_score": 0.339163,
"highlights": [
{
"highlight": "Cantor Fitzgerald has adjusted its price[+153 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "The firm anticipates that <em>Analog</em[+314 characters]",
"sentiment": 0.765,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+297 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+277 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+256 characters]",
"sentiment": 0.7579,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+285 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Points\n\n<em>Analog</em> <em>Dev[+259 characters]",
"sentiment": 0.9062,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Analog</em> <em>Devices</em> (ADI) Price Target Raised Amid Positive Outlook | ADI Stock News",
"sentiment": 0.5574,
"highlighted_in": "title"
}
]
},
{
"symbol": "ANL.DE",
"name": "Analog Devices, Inc.",
"exchange": null,
"exchange_long": null,
"country": "de",
"type": "equity",
"industry": "Technology",
"match_score": 82.43842,
"sentiment_score": 0.339163,
"highlights": [
{
"highlight": "Cantor Fitzgerald has adjusted its price[+153 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "The firm anticipates that <em>Analog</em[+314 characters]",
"sentiment": 0.765,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+297 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+277 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+256 characters]",
"sentiment": 0.7579,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+285 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Points\n\n<em>Analog</em> <em>Dev[+259 characters]",
"sentiment": 0.9062,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Analog</em> <em>Devices</em> (ADI) Price Target Raised Amid Positive Outlook | ADI Stock News",
"sentiment": 0.5574,
"highlighted_in": "title"
}
]
},
{
"symbol": "ADI.MX",
"name": "Analog Devices, Inc.",
"exchange": null,
"exchange_long": null,
"country": "mx",
"type": "equity",
"industry": "Technology",
"match_score": 82.43142,
"sentiment_score": 0.339163,
"highlights": [
{
"highlight": "Cantor Fitzgerald has adjusted its price[+153 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "The firm anticipates that <em>Analog</em[+314 characters]",
"sentiment": 0.765,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+297 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+277 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+256 characters]",
"sentiment": 0.7579,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+285 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Points\n\n<em>Analog</em> <em>Dev[+259 characters]",
"sentiment": 0.9062,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Analog</em> <em>Devices</em> (ADI) Price Target Raised Amid Positive Outlook | ADI Stock News",
"sentiment": 0.5574,
"highlighted_in": "title"
}
]
},
{
"symbol": "0HFN.L",
"name": "Analog Devices, Inc.",
"exchange": null,
"exchange_long": null,
"country": "gb",
"type": "equity",
"industry": "N/A",
"match_score": 82.427864,
"sentiment_score": 0.339163,
"highlights": [
{
"highlight": "Cantor Fitzgerald has adjusted its price[+153 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "The firm anticipates that <em>Analog</em[+314 characters]",
"sentiment": 0.765,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+297 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+277 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+256 characters]",
"sentiment": 0.7579,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+285 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Points\n\n<em>Analog</em> <em>Dev[+259 characters]",
"sentiment": 0.9062,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Analog</em> <em>Devices</em> (ADI) Price Target Raised Amid Positive Outlook | ADI Stock News",
"sentiment": 0.5574,
"highlighted_in": "title"
}
]
}
]
}
]
},
{
"uuid": "d75f7054-e0ba-4dfb-b4bf-f8d267d84b8c",
"title": "Annexon Showcases Tanruprubart Data Demonstrating Improved Clinical Outcomes in Guillain-Barré Syndrome (GBS) at 2025 Peripheral Nerve Society (PNS) Annual Meeting",
"description": "**media[630804]**",
"keywords": "Annexon, Showcases, Tanruprubart, Data, Demonstrating, Improved, Clinical, Outcomes, in, Guillain-Barré, Syndrome, (GBS), at, 2025, Peripheral, Nerve, Society, (PNS), Annual, Meeting",
"snippet": "First Oral Presentation of the Tanruprubart Real-World Evidence (RWE) Study by International Guillain-Barré Syndrome Outcomes Study (IGOS) Researchers Highligh...",
"url": "https://www.manilatimes.net/2025/05/20/tmt-newswire/globenewswire/annexon-showcases-tanruprubart-data-demonstrating-improved-clinical-outcomes-in-guillain-barre-syndrome-gbs-at-2025-peripheral-nerve-society-pns-annual-meeting/2116898",
"image_url": "https://www.manilatimes.net/manilatimes/uploads/images/2025/05/20/630804.png",
"language": "en",
"published_at": "2025-05-19T20:21:05.000000Z",
"source": "manilatimes.net",
"relevance_score": null,
"entities": [
{
"symbol": "GBS",
"name": "GBS Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 32.412216,
"sentiment_score": -0.058773,
"highlights": [
{
"highlight": "<em>GBS</em> is a neuromuscular emergenc[+301 characters]",
"sentiment": -0.7184,
"highlighted_in": "main_text"
},
{
"highlight": "Tanruprubart is a first-in-kind monoclon[+246 characters]",
"sentiment": -0.4939,
"highlighted_in": "main_text"
},
{
"highlight": "\"Currently, outcomes for <em>GBS</em> pa[+211 characters]",
"sentiment": 0.7845,
"highlighted_in": "main_text"
},
{
"highlight": "As the potential first targeted immunoth[+167 characters]",
"sentiment": 0.3612,
"highlighted_in": "main_text"
},
{
"highlight": "In <em>GBS</em>, tanruprubart is designe[+191 characters]",
"sentiment": -0.3832,
"highlighted_in": "main_text"
},
{
"highlight": "Food and Drug Administration as well as [+93 characters]",
"sentiment": 0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "About Guillain-Barré Syndrome (<em>GBS<[+317 characters]",
"sentiment": -0.5267,
"highlighted_in": "main_text"
},
{
"highlight": "<em>GBS</em> results in the hospitalizat[+322 characters]",
"sentiment": -0.2023,
"highlighted_in": "main_text"
},
{
"highlight": "The long-term disease burden associated [+195 characters]",
"sentiment": -0.5994,
"highlighted_in": "main_text"
},
{
"highlight": "patients; the impacts of the new educati[+159 characters]",
"sentiment": 0.3818,
"highlighted_in": "main_text"
},
{
"highlight": "Annexon Showcases Tanruprubart Data Demonstrating Improved Clinical Outcomes in Guillain-Barré Syndrome (<em>GBS</em>) at 2025 Peripheral Nerve Society (PNS) Annual Meeting",
"sentiment": 0.4767,
"highlighted_in": "title"
}
]
}
],
"similar": []
},
{
"uuid": "94f40e2f-3da0-4a0b-9395-f7e9d26236af",
"title": "BigCommerce to Present at Baird Global Consumer, Technology & Services Conference",
"description": "**media[630797]**",
"keywords": "BigCommerce, to, Present, at, Baird, Global, Consumer, , Technology, &, Services, Conference",
"snippet": "AUSTIN, Texas, May 19, 2025 (GLOBE NEWSWIRE) -- BigCommerce Holdings, Inc. (\"BigCommerce”) (Nasdaq: BIGC), an open SaaS, composable ecommerce platform for fas...",
"url": "https://www.manilatimes.net/2025/05/20/tmt-newswire/globenewswire/bigcommerce-to-present-at-baird-global-consumer-technology-services-conference/2116891",
"image_url": "https://www.manilatimes.net/manilatimes/uploads/images/2025/05/20/630797.png",
"language": "en",
"published_at": "2025-05-19T20:20:32.000000Z",
"source": "manilatimes.net",
"relevance_score": null,
"entities": [
{
"symbol": "BIGC",
"name": "BigCommerce Holdings, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Technology",
"match_score": 71.287834,
"sentiment_score": 0.164633,
"highlights": [
{
"highlight": "AUSTIN, Texas, May 19, 2025 (GLOBE NEWSW[+61 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "(\"BigCommerce”) (<em>Nasdaq</em>: <em>[+332 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "About BigCommerce\n\nBigCommerce (<em>Nasd[+210 characters]",
"sentiment": 0.4939,
"highlighted_in": "main_text"
}
]
}
],
"similar": []
},
{
"uuid": "58be6f14-d3f6-4959-bd20-7d6db7b7801f",
"title": "Alpha Tau Announces First Quarter 2025 Financial Results and Provides Corporate Update",
"description": "**media[630783]**",
"keywords": "Alpha, Tau, Announces, First, Quarter, 2025, Financial, Results, and, Provides, Corporate, Update",
"snippet": "- Interim Jan-2025 results from three trials of Alpha DaRT® in treating pancreatic cancer shared at prestigious 2025 ASCO GI Symposium and R&D Update Day, show...",
"url": "https://www.manilatimes.net/2025/05/20/tmt-newswire/globenewswire/alpha-tau-announces-first-quarter-2025-financial-results-and-provides-corporate-update/2116880",
"image_url": "https://www.manilatimes.net/manilatimes/uploads/images/2025/05/20/630783.jpg",
"language": "en",
"published_at": "2025-05-19T20:19:30.000000Z",
"source": "manilatimes.net",
"relevance_score": null,
"entities": [
{
"symbol": "ORMP",
"name": "Oramed Pharmaceuticals Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 19.12414,
"sentiment_score": 0,
"highlights": [
{
"highlight": "Advertisement\n\nRecent Corporate Highligh[+223 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
}
],
"similar": []
}
]
}
Sentiment
Live response for past 24 hours
{
"meta": {
"returned": 1,
"limit": 10
},
"data": [
{
"key": "us",
"total_documents": 3062,
"sentiment_avg": 0.2879044483046328
}
]
}
Other details
Entity count
- 32,649